Hence, it is not surprising that studies that use acetoacetate as the ketone substrate would report increases in cardiac ketone oxidation in experimental models of T2D, since acetoacetate would bypass BDH1 and serve as immediate substrate for up-regulated SCOT activity. This evidence concerns the gene OXCT1 and type 2 diabetes mellitus.